Back to top

Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments

Wells Fargo analyst Derek Archila maintained a Buy rating on Ventyx Biosciences (VTYX – Research Report) yesterday and set a price target of $11.00...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ventyx Biosciences, Inc. (VTYX)